Inovio Pharmaceuticals, Inc.
(NASDAQ : INO)

( )
INO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
1.15%87.020.6%$611.73m
TMOThermo Fisher Scientific Inc.
-0.40%234.541.0%$540.88m
ABTAbbott Laboratories
-0.94%69.810.8%$517.43m
ISRGIntuitive Surgical, Inc.
0.09%515.932.4%$452.79m
BDXBecton, Dickinson and Company
0.22%231.281.1%$294.11m
ALGNAlign Technology, Inc.
6.02%206.796.3%$290.58m
BAXBaxter International Inc.
1.07%68.261.7%$286.03m
BSXBoston Scientific Corporation
-0.30%36.611.1%$270.62m
SYKStryker Corporation
0.72%163.301.3%$253.84m
EWEdwards Lifesciences Corporation
-3.36%156.641.2%$206.28m
ABMDABIOMED, Inc.
-0.46%324.133.3%$189.34m
DXCMDexCom, Inc.
0.00%147.058.5%$178.55m
ZBHZimmer Biomet Holdings, Inc.
0.81%105.011.7%$164.62m
IDXXIDEXX Laboratories, Inc.
0.63%197.243.7%$126.28m
COOCooper Companies, Inc.
1.33%272.262.2%$124.93m

Company Profile

Inovio Pharmaceuticals, Inc. engages in the development of active DNA immunotherapies for cancer and infectious diseases. Its portfolio of immune therapies includes SynCon immunotherapies and electroporation delivery systems. The company was founded on June 29, 1983 and is headquartered in Plymouth Meeting, PA.